CRPC includes the spectrum of PCa ranging from asymptomatic disease to advanced CRPC (metastatic CRPC or mCRPC), characterized by an over-activation and over-expression of the AR, which results in the transcription of downstream target genes that promote carcinogenesis [19,20]. The gene discussed is AR; the disease is posterior cortical atrophy.